首页> 外文期刊>Pakistan journal of medical sciences. >Effects of two genes coding squamous cell carcinoma antigen on the diagnosis and treatment of cervical squamous cell carcinoma
【24h】

Effects of two genes coding squamous cell carcinoma antigen on the diagnosis and treatment of cervical squamous cell carcinoma

机译:两种编码鳞状细胞癌抗原的基因对宫颈鳞癌的诊断和治疗作用

获取原文
           

摘要

Objective: To study the effects of expressions of SCCA1 and SCCA2 in cervical squamous cell carcinoma on its diagnosis, treatment evaluation and prognosis analysis.Methods: Seventy-six cervical squamous cell carcinoma patients enrolled in our hospital from October 2011 to April 2013 were selected, and another 76 healthy females (without cervical tissue lesions) were enrolled as the control. SCCA1 and SCCA2 expressions in the two groups were compared by RT-PCR. The serodiagnosis results before and after chemotherapy were compared to clarify the effects of SCCA2 expression.Results: The two groups had similar relative SCCA1 expression rates that were not significantly correlated with pathological factors. Before chemotherapy, the relative expression rates of SCCA2 were significantly higher in the patients with later stage (t=6.018, P=0.00082 < 0.05) and lymphatic metastasis (t=6.281, P=0.00192 < 0.05). After treatment, relative SCCA2 expression rate was decreased more significantly in the effective group than that in the ineffective group (t=10.27893, P=0.02815 < 0.05).Conclusion: The expression of SCCA1 failed to indicate the onset, diagnosis and prevention of cervical squamous cell carcinoma, whereas that of SCCA2 worked as one of the tumor markers.doi: http://dx.doi.org/10.12669/pjms.302.4374How to cite this:Yin Q, Wang Y, Zheng C, Liu Y, Chen Z, Lu F, et al. Effects of two genes coding squamous cell carcinoma antigen on the diagnosis and treatment of cervical squamous cell carcinoma. Pak J Med Sci 2014;30(2):282-286. doi: http://dx.doi.org/10.12669/pjms.302.4374This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
机译:目的:探讨SCCA1和SCCA2在宫颈鳞癌中的表达对其诊断,治疗效果和预后的影响。方法:选择2011年10月至2013年4月在我院就诊的76例宫颈鳞癌患者,另有76例健康女性(无宫颈组织病变)作为对照。用RT-PCR比较两组SCCA1和SCCA2的表达。比较化疗前后的血清学诊断结果,以明确SCCA2表达的影响。结果:两组相对SCCA1表达率相似,与病理因素无显着相关。化疗前,晚期(t = 6.018,P = 0.00082 <0.05)和淋巴结转移(t = 6.281,P = 0.00192 <0.05)的患者SCCA2的相对表达率显着较高。治疗后,有效组SCCA2相对表达率较无效组明显降低(t = 10.27893,P = 0.02815 <0.05)。结论:SCCA1的表达未能提示宫颈癌的发生,诊断和预防。鳞状细胞癌,而SCCA2的鳞状细胞癌是肿瘤标志物之一。doi:http://dx.doi.org/10.12669/pjms.302.4374如何引述:尹Q,王Y,郑C,刘Y, Chen Z,Lu F等。两种编码鳞状细胞癌抗原的基因对子宫颈鳞状细胞癌的诊断和治疗的影响。 Pak J Med Sci 2014; 30(2):282-286。 doi:http://dx.doi.org/10.12669/pjms.302.4374这是根据知识共享署名许可(http://creativecommons.org/licenses/by/3.0)条款发布的开放获取文章,允许在任何媒体中无限制地使用,分发和复制,但要正确引用原始作品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号